NO975831L - Nytt farmasöytisk preparat med anestetisk virkning - Google Patents

Nytt farmasöytisk preparat med anestetisk virkning

Info

Publication number
NO975831L
NO975831L NO975831A NO975831A NO975831L NO 975831 L NO975831 L NO 975831L NO 975831 A NO975831 A NO 975831A NO 975831 A NO975831 A NO 975831A NO 975831 L NO975831 L NO 975831L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
new pharmaceutical
anesthetic effect
anesthetic
effect
Prior art date
Application number
NO975831A
Other languages
English (en)
Other versions
NO318239B1 (no
NO975831D0 (no
Inventor
Arne Brodin
Raymond Fynes
Lars Heijl
Adela Nyqvist-Mayer
Marie Scherlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO975831L publication Critical patent/NO975831L/no
Publication of NO975831D0 publication Critical patent/NO975831D0/no
Publication of NO318239B1 publication Critical patent/NO318239B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19975831A 1996-04-12 1997-12-11 Farmasoytisk preparat med anestetisk virkning, fremgangsmate for fremstilling av samme og anvendelse for fremstilling av medikament. NO318239B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601421A SE9601421D0 (sv) 1996-04-12 1996-04-12 New composition
PCT/SE1997/000566 WO1997038675A1 (en) 1996-04-12 1997-04-01 New pharmaceutical composition with anaesthetic effect

Publications (3)

Publication Number Publication Date
NO975831L true NO975831L (no) 1997-12-11
NO975831D0 NO975831D0 (no) 1997-12-11
NO318239B1 NO318239B1 (no) 2005-02-21

Family

ID=20402194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975831A NO318239B1 (no) 1996-04-12 1997-12-11 Farmasoytisk preparat med anestetisk virkning, fremgangsmate for fremstilling av samme og anvendelse for fremstilling av medikament.

Country Status (29)

Country Link
US (1) US6031007A (no)
EP (1) EP0833612B1 (no)
JP (2) JPH11501678A (no)
KR (1) KR100508601B1 (no)
CN (1) CN1149072C (no)
AR (1) AR006484A1 (no)
AT (1) ATE248584T1 (no)
AU (1) AU716540B2 (no)
BR (1) BR9702147A (no)
CA (1) CA2222676C (no)
CZ (1) CZ371197A3 (no)
DE (1) DE69724545T2 (no)
DK (1) DK0833612T3 (no)
EE (1) EE9700363A (no)
ES (1) ES2203799T3 (no)
HU (1) HUP9903544A3 (no)
ID (1) ID16420A (no)
IL (1) IL122447A (no)
IS (1) IS4618A (no)
NO (1) NO318239B1 (no)
NZ (1) NZ329246A (no)
PL (1) PL324170A1 (no)
RU (1) RU2185153C2 (no)
SE (1) SE9601421D0 (no)
SK (1) SK169897A3 (no)
TR (1) TR199701584T1 (no)
TW (1) TW473386B (no)
WO (1) WO1997038675A1 (no)
ZA (1) ZA973022B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
KR100416646B1 (ko) * 2000-08-14 2004-02-05 구주제약주식회사 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물
GB0120701D0 (en) 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
US20040087520A1 (en) * 2002-10-25 2004-05-06 Chowdhury Dipak K. Compositions and methods for delivery of therapeutic agents
TW200410717A (en) * 2002-12-31 2004-07-01 Ind Tech Res Inst Delivery system for control release of temperature sensitive bioactive material
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
BR0301968A (pt) * 2003-05-22 2005-06-28 Cristalia Prod Quimicos Farm Misturas eutéticas ternárias e quaternárias constituìdas por substâncias anestésicas locais, seu emprego no preparo de composições farmacêuticas e seu uso em anestesia e analgesia tópica
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
US7943179B2 (en) * 2003-09-23 2011-05-17 Massachusetts Institute Of Technology pH triggerable polymeric particles
US20050123596A1 (en) * 2003-09-23 2005-06-09 Kohane Daniel S. pH-triggered microparticles
US20070232695A1 (en) * 2004-01-28 2007-10-04 Collegium Pharmaceutical, Inc. Gelled Periodontal Anesthetic Preparation
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
RU2274446C2 (ru) * 2004-07-02 2006-04-20 Наталья Александровна Уракова Средство для локальной инъекционной химиоанестезии
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US7718674B2 (en) * 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
US20090123527A1 (en) * 2006-07-24 2009-05-14 Akorn, Inc. Method of inducing topical anesthesia and transdermal patch
US20080021068A1 (en) * 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9012477B2 (en) 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
SG175327A1 (en) * 2009-04-22 2011-11-28 Agency Science Tech & Res Emulsions for transdermal delivery
WO2011074015A2 (en) 2009-12-17 2011-06-23 Themis Medicare Limited Novel composition of pharmaceutical product to treat sexual dysfunction
US9693976B2 (en) 2010-01-14 2017-07-04 Crescita Therapeutics Inc. Solid-forming local anesthetic formulations for pain control
RU2435603C1 (ru) * 2010-03-17 2011-12-10 Федеральное государственное учреждение "Центральный научно-исследовательский институт стоматологии и челюстно-лицевой хирургии" Федерального агентства по высокотехнологичной медицинской помощи Состав для местной анестезии и лечения воспалительных заболеваний слизистой оболочки полости рта
KR20130080435A (ko) 2010-04-01 2013-07-12 파마네스트 아베 국소마취의 생체 점착성 조성물
US20140066481A1 (en) 2010-04-01 2014-03-06 Pharmanest Ab Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics
AU2011234492B2 (en) * 2010-04-01 2014-02-27 Palette Life Sciences AB Thermogelling anaesthetic compositions
EP2560626A4 (en) * 2010-04-21 2013-09-18 Teikoku Pharma Usa Inc EMULSIONAL COMPOSITIONS FOR LOCAL ANESTHESIA AND METHOD FOR THE PRODUCTION AND USE THEREOF
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
EP2968247A4 (en) * 2013-03-14 2017-04-26 Jsn I Llc Taste masking of anesthetics and analgesics
EP3344230B1 (en) 2015-09-02 2022-04-06 T.C. Istanbul Medipol Universitesi Formulations of benzocaine loaded microemulsion based hydrogels for therapeutic purposes and their production method
WO2020182535A1 (en) 2019-03-08 2020-09-17 Bayer Oy Uterine sound tube with anaesthetic applicator
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
US5292516A (en) * 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
CA2040460C (en) * 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
FR2704429B3 (fr) * 1993-04-30 1995-07-13 Algovital Sarl Formulation associant une réaction alcaline et des composants d'huiles essentielles pour réaliser une anesthésie locale, par voie externe, transcutanée, sans injection.
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof

Also Published As

Publication number Publication date
ZA973022B (en) 1997-10-13
JPH11501678A (ja) 1999-02-09
TR199701584T1 (xx) 1999-03-22
CN1149072C (zh) 2004-05-12
NO318239B1 (no) 2005-02-21
EP0833612A1 (en) 1998-04-08
HUP9903544A2 (hu) 2000-06-28
ES2203799T3 (es) 2004-04-16
IS4618A (is) 1997-11-21
MX9709941A (es) 1998-03-29
DK0833612T3 (da) 2003-12-01
EE9700363A (et) 1998-06-15
EP0833612B1 (en) 2003-09-03
JP2004149544A (ja) 2004-05-27
RU2185153C2 (ru) 2002-07-20
BR9702147A (pt) 1999-07-20
DE69724545D1 (de) 2003-10-09
IL122447A0 (en) 1998-06-15
DE69724545T2 (de) 2004-06-03
HUP9903544A3 (en) 2000-07-28
NO975831D0 (no) 1997-12-11
AR006484A1 (es) 1999-08-25
CA2222676C (en) 2008-01-22
AU716540B2 (en) 2000-02-24
PL324170A1 (en) 1998-05-11
IL122447A (en) 2001-04-30
KR100508601B1 (ko) 2006-03-23
NZ329246A (en) 2000-06-23
ATE248584T1 (de) 2003-09-15
SE9601421D0 (sv) 1996-04-12
WO1997038675A1 (en) 1997-10-23
SK169897A3 (en) 1998-07-08
AU2416897A (en) 1997-11-07
CA2222676A1 (en) 1997-10-23
CN1188407A (zh) 1998-07-22
TW473386B (en) 2002-01-21
ID16420A (id) 1997-09-25
HK1010144A1 (en) 1999-06-17
US6031007A (en) 2000-02-29
KR19990022833A (ko) 1999-03-25
CZ371197A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
NO975831D0 (no) Nytt farmasöytisk preparat med anestetisk virkning
DK0946510T3 (da) Hidtil ukendte forbindelser med analgetisk virkning
NO973612L (no) Nytt farmasöytisk preparat
NO306446B1 (no) Oralt farmasöytisk preparat omfattende tramadol med regulert frigjöringsvirkning
NO20003218D0 (no) Oralfarmasøytisk doseringsform med forlenget frigivningsvirkning
NO20001160D0 (no) Nytt skumdannende farmasøytisk preparat
NO943888D0 (no) Farmasöytisk preparat
NO963032D0 (no) Oralt preparat
NO20005399D0 (no) Farmasøytisk preparat
DK0934057T3 (da) Medicinske aerosolformuleringer med formoterol
DK1466615T3 (da) Farmaceutisk præparat
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
NO942343L (no) Farmasöytisk preparat med analgetisk aktivitet
NO973610D0 (no) Nytt farmasöytisk preparat
EE9800451A (et) Uued imidasotriasolopürimidiinid, nende valmistamismeetod ja kasutamine ravimainetena
NO973611D0 (no) Nytt farmasöytisk preparat
FI951155A0 (fi) Farmaseuttinen valmiste
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
FI961364L (fi) Lääkeainekoostumus
NO971879D0 (no) Preparat for transdermal administrasjon
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
ATA77096A (de) Pharmazeutische präparation
NO965332D0 (no) Terapeutisk perparat
SK1380U (sk) Farmaceutický preparát
DK0946511T3 (da) Hidtil ukendte forbindelser med analgesisk virkning

Legal Events

Date Code Title Description
MK1K Patent expired